Modeling the ternary complex TCR-Vβ/collagenii(261-273)/HLA-DR4 associated with rheumatoid arthritis

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  de Rosa, Maria Cristina ^a   Giardina, Bruno ^b   Bianchi, Caterina ^b   Alinovi, Cristiana Carelli ^b   Pirolli, Davide ^b   Ferraccioli, Gianfranco ^b   de Santis, Maria ^b   di Sante, Gabriele ^b   Ria, Francesco ^b  

^a CNR   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; EPITOPE; HLA DR4 ANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR V BETA; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; CONFORMATION; DISEASE PREDISPOSITION; HUMAN; MOLECULAR DOCKING; MOLECULAR DYNAMICS; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RHEUMATOID ARTHRITIS; SEQUENCE HOMOLOGY; SIMULATION; COMPUTER SIMULATION; GENETICS; METABOLISM;

ARTHRITIS, RHEUMATOID; COLLAGEN TYPE II; COMPUTER SIMULATION; HLA-DR4 ANTIGEN; HUMANS; MOLECULAR DYNAMICS SIMULATION; RECEPTORS, ANTIGEN, T-CELL;

EID: 77955354420     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011550     Document Type: Article

References (42)

1. Davis MM, Bjorkman PJ (1988) T-cell antigen receptor genes and T-cell recognition. Nature 334: 395-402.
2. Starr TK, Jameson SC, Hogquist KA (2003) Positive and negative selection of T cells. Annu Rev Immunol 21: 139-176.
3. Russell AS (2008) Quality-of-life assessment in rheumatoid arthritis. Pharmacoeconomics 26: 831-846.
4. Nepom GT, Byers P, Seyfried C, Healey LA, Wilske KR, et al. (1989) HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum 32: 15-21.
5. Wordsworth BP, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, et al. (1989) HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci U S A 86: 10049-10053.
6. Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30: 1205-1213.
7. Fu XT, Bono CP, Woulfe SL, Swearingen C, Summers NL, et al. (1995) Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide. J Exp Med 181: 915-926.
8. Signorelli KL, Watts LM, Lambert LE (1995) The importance of DR4Dw4 beta chain residues 70, 71, and 86 in peptide binding and T cell recognition. Cell Immunol 162: 217-224.
9. Hiraiwa A, Yamanaka K, Kwok WW, Mickelson EM, Masewicz S, et al. (1990) Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis. Proc Natl Acad Sci U S A 87: 8051-8055.
10. Watson WC, Tooms RE, Carnesale PG, Dutkowsky JP (1994) A case of germinal center formation by CD45RO T and CD20 B lymphocytes in rheumatoid arthritic subchondral bone: proposal for a two-compartment model of immune-mediated disease with implications for immunotherapeutic strategies. Clin Immunol Immunopathol 73: 27-37.
11. Londei M, Savill CM, Verhoef A, Brennan F, Leech ZA, et al. (1989) Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci U S A 86: 636-640.
12. Kjellen P, Brunsberg U, Broddefalk J, Hansen B, Vestberg M, et al. (1998) The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules. Eur J Immunol 28: 755-767.
13. Fridkis-Hareli M, Rosloniec EF, Fugger L, Strominger JL (2000) Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagenspecific T-cell responses. Hum Immunol 61: 640-650.
14. Garcia KC, Teyton L, Wilson IA (1999) Structural basis of T cell recognition. Annu Rev Immunol 17: 369-397.
15. Ria F, Penitente R, De Santis M, Nicolo C, Di Sante G, et al. (2008) Collagenspecific T-cell repertoire in blood and synovial fluid varies with disease activity in early rheumatoid arthritis. Arthritis Res Ther 10: R135.
16. Ria F, van den Elzen P, Madakamutil LT, Miller JE, Maverakis E, et al. (2001) Molecular characterization of the T cell repertoire using immunoscope analysis and its possible implementation in clinical practice. Curr Mol Med 1: 297-304.
17. Li Y, Huang Y, Lue J, Quandt JA, Martin R, et al. (2005) Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. EMBO J 24: 2968-2979.
18. Gouet P, Courcelle E, Stuart DI, Metoz F (1999) ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 15: 305-308.
19. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234: 779-815.
20. Luthy R, Bowie JU, Eisenberg D (1992) Assessment of protein models with three-dimensional profiles. Nature 356: 83-85.
21. Morris AL, MacArthur MW, Hutchinson EG, Thornton JM (1992) Stereochemical quality of protein structure coordinates. Proteins 12: 345-364.
22. Dessen A, Lawrence CM, Cupo S, Zaller DM, Wiley DC (1997) X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 7: 473-481.
23. Gabb HA, Jackson RM, Sternberg MJ (1997) Modelling protein docking using shape complementarity, electrostatics and biochemical information. J Mol Biol 272: 106-120.
24. Katchalski-Katzir E, Shariv I, Eisenstein M, Friesem AA, Aflalo C, et al. (1992) Molecular surface recognition: determination of geometric fit between proteins and their ligands by correlation techniques. Proc Natl Acad Sci U S A 89: 2195-2199.
25. Brooks BR, Brooks CL, 3rd, Mackerell AD, Jr., Nilsson L, Petrella RJ, et al. (2009) CHARMM: the biomolecular simulation program. J Comput Chem 30: 1545-1614.
26. Jones S, Thornton JM (1996) Principles of protein-protein interactions. Proc Natl Acad Sci U S A 93: 13-20.
27. Hennecke J, Wiley DC (2002) Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. J Exp Med 195: 571-581.
28. Wu LC, Tuot DS, Lyons DS, Garcia KC, Davis MM (2002) Two-step binding mechanism for T-cell receptor recognition of peptide MHC. Nature 418: 552-556.
29. Rudolph MG, Stanfield RL, Wilson IA (2006) How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 24: 419-466.
30. Stocker U, van Gunsteren WF (2000) Molecular dynamics simulation of hen egg white lysozyme: a test of the GROMOS96 force field against nuclear magnetic resonance data. Proteins 40: 145-153.
31. Kortemme T, Baker D (2002) A simple physical model for binding energy hot spots in protein-protein complexes. Proc Natl Acad Sci U S A 99: 14116-14121.
32. Kortemme T, Kim DE, Baker D (2004) Computational alanine scanning of protein-protein interfaces. Sci STKE 2004: 1-8.
33. Deng L, Mariuzza R (2007) Recognition of self-peptide-MHC complexes by autoimmune T-cell receptors. Trends Biochem Sci 32: 500-508.
34. Armstrong KM, Piepenbrink KH, Baker BM (2008) Conformational changes and flexibility in T-cell receptor recognition of peptide-MHC complexes. Biochem J 415: 183-196.
35. Hammer J, Gallazzi F, Bono E, Karr RW, Guenot J, et al. (1995) Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med 181: 1847-1855.
36. Wilson D, Pinilla C, Wilson D, Schroder K, Boggiano C, et al. (1999) Immunogenicity. I. Use of peptide libraries to identify epitopes that activate clonotypic CD4+ T cells and induce T cell responses to native peptide ligands. J Immunol 163: 6424-6434.
37. Hausmann S, Martin M, Gauthier L, Wucherpfennig K (1999) Structural features of autoreactive TCR that determine the degree of degeneracy in peptide recognition. J Immunol 162: 338-344.
38. Rosloniec E, Whittington K, Zaller D, Kang A (2002) HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen. J Immunol 168: 253-259.
39. Collins EJ, Riddle DS (2008) TCR-MHC docking orientation: natural selection, or thymic selection? Immunol Res 41: 267-294.
40. Iezzi G, Scotet E, Scheidegger D, Lanzavecchia A (1999) The interplay between the duration of TCR and cytokine signaling determines T cell polarization. Eur J Immunol 29: 4092-4101.
41. Badou A, Savignac M, Moreau M, Leclerc C, Foucras G, et al. (2001) Weak TCR stimulation induces a calcium signal that triggers IL-4 synthesis, stronger TCR stimulation induces MAP kinases that control IFN-gamma production. Eur J Immunol 31: 2487-2496.
42. Sakurai Y, Brand D, Tang B, Rosloniec E, Stuart J, et al. (2006) Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice. Arthritis Res Ther 8: R150.